Literature DB >> 10224170

Association between diabetes control and visits to a multidisciplinary pediatric diabetes clinic.

F R Kaufman1, M Halvorson, S Carpenter.   

Abstract

OBJECTIVE: To determine if there is a relationship between diabetes outcome as measured by HbA1C and the number of multidisciplinary clinic visits per year in children and youth with diabetes. RESEARCH DESIGN AND METHODS: The number of clinic visits per year, the mean HbA1C (by DCA 2000, Miles, Tarrytown, NY), type of insurance, parental marital status, parental age, maximal parental grade level achieved, family income, self-identified race, and scores on adherence and knowledge tests were compared for 1995 in 360 patients with a mean age of 11.6 +/- 4.8 years (1-2 visits, 85 patients; 3-4 visits, 275 patients), for 1996 in 412 patients with a mean age of 11.6 +/- 4.7 years (1-2 visits, 115 patients; 3-4 visits, 297 patients), and for 1997 in 442 patients with a mean age of 11.8 +/- 4.9 years (1-2 visits, 126 patients; 3-4 visits, 332 patients).
RESULTS: There was a significant difference in the mean HbA1C levels between subjects with 1 to 2 visits versus 3 to 4 visits during the 3 years of this study. In 1995, the mean HbA1C was 9.0 +/- 2.0% for subjects with 1 to 2 visits and 8.3 +/- 1.6% for subjects with 3 to 4 visits. In 1996, the mean HbA1C was 9.3 +/- 2.0% for subjects with 1 to 2 visits and 8.4 +/- 1.6% in those with 3 to 4 visits, whereas in 1997, the mean HbA1C was 9.1 +/- 1.9% with 1 to 2 visits and 8.3 +/- 1.5% with 3 to 4 visits. There was a significant difference in the number of visits by the age of the subject. The mean age of patients with 1 to 2 visits was 13.6 +/- 4.5 years; it was 10.8 +/- 4.6 years with 3 to 4 visits. However, for age groups <13 years versus >/=13 years, there was still a difference between HbA1C levels for subjects with 1 to 2 visits compared with 3 to 4 visits (8.9 +/- 1.7% versus 8.1 +/- 1.3%, respectively). The only patient/family characteristic that had an association with number of visits was the marital status of the parents. Children from single-parent households had fewer visits. There was no association between health insurance status and number of visits and there was no difference between the number of visits and the mean scores on tests of adherence or knowledge. Multivariate analysis showed that the number of visits was a significant predictor of HbA1C even after controlling for age, duration of diabetes, and scores on adherence and knowledge tests.
CONCLUSIONS: The finding that subjects with more frequent visits to a multidisciplinary diabetes clinic had lower HbA1C levels during the 3 years of this study suggests that strategies should be developed to promote adherence with quarterly visits, particularly targeted to children from single-parent households and to teens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10224170     DOI: 10.1542/peds.103.5.948

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  29 in total

1.  A pilot study of acute stress symptoms in parents and youth following diagnosis of type I diabetes.

Authors:  Ginger Depp Cline; David D Schwartz; Marni E Axelrad; Barbara Anderson
Journal:  J Clin Psychol Med Settings       Date:  2011-12

2.  Multisystemic Therapy Improves the Patient-Provider Relationship in Families of Adolescents with Poorly Controlled Insulin Dependent Diabetes.

Authors:  April Idalski Carcone; Deborah A Ellis; Xinguang Chen; Sylvie Naar; Phillippe B Cunningham; Kathleen Moltz
Journal:  J Clin Psychol Med Settings       Date:  2015-09

3.  Televisits to Partially Substitute for Clinic Visits Are Feasible and Well Accepted by Tech-Savvy Patients With T1DM and Their Families: A Prospective Pilot Study.

Authors:  Ksenia N Tonyushkina; Victoria Cobb; Alexander Moskovitz; Holley F Allen
Journal:  J Diabetes Sci Technol       Date:  2018-05-22

4.  Care utilization in a pediatric diabetes clinic: cancellations, parental attendance, and mental health appointments.

Authors:  Jessica T Markowitz; Lisa K Volkening; Lori M B Laffel
Journal:  J Pediatr       Date:  2014-03-06       Impact factor: 4.406

5.  Pharmaceutical care of adolescents with diabetes mellitus type 1: the DIADEMA study, a randomized controlled trial.

Authors:  Emina Obarcanin; Manfred Krüger; Petra Müller; Verena Nemitz; Holger Schwender; Snijezana Hasanbegovic; Sena Kalajdzisalihovic; Stephanie Läer
Journal:  Int J Clin Pharm       Date:  2015-04-28

6.  Play-Based Interventions Delivered by Child Life Specialists: Teachable Moments for Youth With Type 1 Diabetes.

Authors:  Rebecca Ortiz La Banca; Deborah A Butler; Lisa K Volkening; Lori M Laffel
Journal:  J Pediatr Health Care       Date:  2020-04-03       Impact factor: 1.812

7.  Long-term glycemic control as a result of initial education for children with new onset type 1 diabetes: does the setting matter?

Authors:  Susanne M Cabrera; Nayan T Srivastava; Jennifer M Behzadi; Tina M Pottorff; Linda A Dimeglio; Emily C Walvoord
Journal:  Diabetes Educ       Date:  2013-02-20       Impact factor: 2.140

8.  White Coat Adherence in Pediatric Patients With Type 1 Diabetes Who Use Insulin Pumps.

Authors:  Kimberly A Driscoll; Yuxia Wang; Suzanne Bennett Johnson; Rebecca Lynch; Haley Stephens; Katelyn Willbur; Elizabeth Gill; Nancy Wright; Larry C Deeb
Journal:  J Diabetes Sci Technol       Date:  2016-05-03

9.  Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade.

Authors:  E-M Gerstl; W Rabl; J Rosenbauer; H Gröbe; S E Hofer; U Krause; R W Holl
Journal:  Eur J Pediatr       Date:  2007-10-09       Impact factor: 3.183

10.  Computerized Automated Reminder Diabetes System (CARDS): e-mail and SMS cell phone text messaging reminders to support diabetes management.

Authors:  David A Hanauer; Katherine Wentzell; Nikki Laffel; Lori M Laffel
Journal:  Diabetes Technol Ther       Date:  2009-02       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.